Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ecstasy”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Early research (Phase 1)Study completedNCT01447472
What this trial is testing

-Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms

Who this might be right for
MetabolismInteraction
Parc de Salut Mar 27
Large-scale testing (Phase 3)Looking for participantsNCT06394284
What this trial is testing

Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

Who this might be right for
PTSD, Post Traumatic Stress DisorderMoral Injury
Herzog Hospital 60
Early research (Phase 1)Study completedNCT05809271
What this trial is testing

Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 25
Testing effectiveness (Phase 2)Looking for participantsNCT07301632
What this trial is testing

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial

Who this might be right for
Chronic Neuropathic Pain
Unity Health Toronto 50
Testing effectiveness (Phase 2)Study completedNCT02427568
What this trial is testing

MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

Who this might be right for
Anxiety
Resilient Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00990067
What this trial is testing

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Who this might be right for
Mood DisorderSubstance-Related DisordersAmphetamine-Related Disorders
University Hospital, Basel, Switzerland 16
Very early researchStudy completedNCT01616407
What this trial is testing

Effects of MDMA and Methylphenidate on Social Cognition

Who this might be right for
Social Cognition
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Study completedNCT00090064
What this trial is testing

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Who this might be right for
Posttraumatic Stress Disorder
Resilient Pharmaceuticals 23
Large-scale testing (Phase 3)Active Not RecruitingNCT06117306
What this trial is testing

MDMA-assisted Massed Prolonged Exposure for PTSD

Who this might be right for
Post-Traumatic Stress Disorder
Healing Breakthrough 20
Testing effectiveness (Phase 2)Study completedNCT00353938
What this trial is testing

Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder

Who this might be right for
Posttraumatic Stress Disorder
Resilient Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT01689740
What this trial is testing

Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD

Who this might be right for
Posttraumatic Stress Disorder (PTSD)
Resilient Pharmaceuticals 10
Early research (Phase 1)Study completedNCT01386177
What this trial is testing

Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)

Who this might be right for
Mood DisorderSubstance-Related DisordersAmphetamine-Related Disorders
University Hospital, Basel, Switzerland 16
Early research (Phase 1)Study completedNCT01404754
What this trial is testing

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers

Who this might be right for
Psychological Effects of Study Drug
Resilient Pharmaceuticals 107
Not applicableStudy completedNCT02342366
What this trial is testing

Characterization of the Prosocial and Prosexual Effects of GHB

Who this might be right for
Depressive Disorder, MajorBipolar DisorderAutistic Disorder
University of Zurich 19
Not applicableStudy completedNCT02102802
What this trial is testing

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

Who this might be right for
Posttraumatic Stress Disorder
Resilient Pharmaceuticals 10
Very early researchStudy completedNCT05379959
What this trial is testing

Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function

Who this might be right for
Stimulant UseMDMA ('Ecstasy')Social Behavior+1 more
University of Chicago 43
Early research (Phase 1)Not Yet RecruitingNCT03606538
What this trial is testing

MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function

Who this might be right for
PharmacokineticsHepatic Impairment
Resilient Pharmaceuticals 16
Not applicableNot Yet RecruitingNCT07555132
What this trial is testing

Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls

Who this might be right for
Autism Spectrum Disorder
University Hospital, Basel, Switzerland 40
Very early researchActive Not RecruitingNCT06565494
What this trial is testing

MDMA-Assisted Therapy for Pathological Narcissism

Who this might be right for
Narcissism
University of Washington 12
Early research (Phase 1)Study completedNCT00886886
What this trial is testing

Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)

Who this might be right for
Mood DisorderSubstance-related DisordersAmphetamine-related Disorders
University Hospital, Basel, Switzerland 16
Next Page